Global Bioabsorbable Stent/Bioresorbable Scaffold Market Size By Type (DONE, Type II), By Application (Coronary Artery Disease, Peripheral Artery Disease), By Region, And Segment Forecasts, 2023 to 20...

The Global Bioabsorbable Stent/Bioresorbable Scaffold Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.8 billion by 2031, growing at a CAGR of 11.5% during the forecast period from 2023 to 2031. The growth of this market is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs), technological advancements in bioresorbable materials, and the rising demand for minimally invasive procedures. Bioabsorbable stents are gaining traction as they eliminate long-term complications associated with permanent metallic implants, offering superior vessel healing and restoration of natural vascular function.

Drivers:

Rising Prevalence of Cardiovascular Diseases:

An increase in the global burden of CVDs, especially coronary artery disease (CAD), has significantly propelled the demand for bioabsorbable stents. These devices are proving effective in reducing restenosis rates and eliminating long-term foreign body complications.

Technological Advancements:

Continuous R&D efforts have led to the development of next-generation bioresorbable scaffolds with improved mechanical strength, biocompatibility, and degradation profiles, enhancing patient outcomes.

Growing Demand for Minimally Invasive Procedures:

Patients and healthcare providers are increasingly preferring minimally invasive cardiovascular interventions, which offer reduced hospital stays, quicker recovery, and lower procedural risks — all of which are supported by bioabsorbable stent technology.

Restraints:

High Cost of Bioabsorbable Stents:

Despite their benefits, the high cost of bioabsorbable stents compared to traditional metallic stents poses a significant barrier to market growth, particularly in price-sensitive developing economies.

Stringent Regulatory Approvals:

Obtaining regulatory approval for bioabsorbable stents is complex and time-consuming due to safety concerns, stringent clinical trial requirements, and the need for extensive long-term data.

Opportunity:

Expanding Applications Beyond Coronary Artery Disease:

Emerging applications of bioresorbable scaffolds in peripheral artery disease (PAD) and pediatric cardiology present new growth opportunities for market players.

Market Growth in Emerging Economies:

Rising healthcare expenditure, increasing awareness about cardiovascular health, and expanding healthcare infrastructure in Asia-Pacific and Latin America are expected to drive market expansion.

Market by System Type Insights:

Based on system type, the Polymer-based Bioabsorbable Stents segment dominated the market in 2023. Polymer-based stents are widely adopted due to their flexibility, bio-compatibility, and efficient drug delivery capabilities. However, the Metal-based Bioresorbable Scaffolds segment is anticipated to witness the highest growth during the forecast period owing to enhanced radial strength and controlled degradation profiles.

Market by End-use Insights:

In terms of end-use, the Hospitals segment accounted for the largest market share in 2023. Hospitals are preferred for complex cardiovascular interventions due to the availability of advanced healthcare infrastructure and specialized cardiac care units. The Ambulatory Surgical Centers (ASCs) segment is expected to grow rapidly, driven by the increasing preference for same-day procedures and cost-effective treatment options.

Market by Regional Insights:

Geographically, North America led the Global Bioabsorbable Stent/Bioresorbable Scaffold Market in 2023, supported by high healthcare spending, advanced healthcare infrastructure, and early adoption of innovative medical devices. Asia-Pacific is projected to register the highest growth rate during the forecast period, driven by the rising prevalence of CVDs, growing medical tourism, and expanding healthcare access in countries like China and India.

Competitive Scenario:

Key players operating in the Global Bioabsorbable Stent/Bioresorbable Scaffold Market include Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Reva Medical LLC, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Arterius Limited, Meril Life Sciences Pvt. Ltd., and Amaranth Medical Inc.

These companies are focusing on product innovation, strategic collaborations, and expanding their global presence to strengthen their market position.

Key Market Developments:

In 2023, Abbott Laboratories launched its next-generation bioabsorbable vascular scaffold featuring enhanced polymer technology for better patient outcomes.

In 2022, Boston Scientific acquired a majority stake in a bioresorbable stent startup to strengthen its product portfolio in the interventional cardiology space.

In 2024, Biotronik SE announced the launch of its magnesium-based bioresorbable scaffold in the European market, focusing on improved vascular healing.

Scope of Work – Global Bioabsorbable Stent/Bioresorbable Scaffold Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.8 billion

CAGR (2023-2031) 11.5%

Key Segments by System Type Polymer-based Stents, Metal-based Scaffolds

Key Segments by End-use Hospitals, Ambulatory Surgical Centers (ASCs), Others

Leading Region North America

Key Players Abbott Laboratories, Boston Scientific Corporation, Biotronik SE, Reva Medical, Elixir Medical, Meril Life Sciences

FAQs:

1. What is the current market size of the Global Bioabsorbable Stent/Bioresorbable Scaffold Market?

The market was valued at USD 1.2 billion in 2023.

2. What is the major growth driver of the Global Bioabsorbable Stent/Bioresorbable Scaffold Market?

The market is driven by the rising prevalence of cardiovascular diseases and technological advancements in bioresorbable materials.

3. Which is the largest region during the forecast period in the Global Bioabsorbable Stent/Bioresorbable Scaffold Market?

North America is expected to remain the largest region during the forecast period due to advanced healthcare infrastructure and early adoption of innovative technologies.

4. Which segment accounted for the largest market share in the Global Bioabsorbable Stent/Bioresorbable Scaffold Market?

The Polymer-based Bioabsorbable Stents segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Bioabsorbable Stent/Bioresorbable Scaffold Market?

Key players include Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Reva Medical LLC, and Elixir Medical Corporation.